We are live on ! Find out more
BNP Paribas Financial Markets

BNP Paribas Financial Markets Portfolio holdings

AUM $289B
1-Year Est. Return 60.46%
 

BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.

This Fund
S&P 500
This Quarter Est. Return
-13.64%
1 Year Est. Return
+60.46%
3 Year Est. Return
+148.24%
5 Year Est. Return
+163.86%
10 Year Est. Return
+570.16%
AUM
$42.3B
AUM Growth
-$25.4B
Cap. Flow
-$18.9B
Cap. Flow %
-44.7%
Top 10 Hldgs %
18.81%
Holding
4,572
New
126
Increased
1,431
Reduced
2,296
Closed
248

Sector Composition

Rank Sector Weight
1 Technology 7%
2 Financials 5.86%
3 Healthcare 5.05%
4 Consumer Discretionary 4.98%
5 Industrials 3.53%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CHK
3676
PUT
DELISTED
Chesapeake Energy Corporation
CHK
-5
Closed -$3.44K
SHLO
3677
DELISTED
Shiloh Industries Inc
SHLO
$2.26K ﹤0.01%
388
-191
-33% -$1.52K
LGTY
3678
DELISTED
Logility Supply Chain Solutions, Inc. Common Stock
LGTY
$2.26K ﹤0.01%
216
-677
-76% -$7.48K
SPRO icon
3679
Spero Therapeutics
SPRO
$71.8M
$2.25K ﹤0.01%
366
+145
+66% +$1.17K
SBSW icon
3680
Sibanye-Stillwater
SBSW
$7.42B
$2.23K ﹤0.01%
789
AINC
3681
DELISTED
Ashford Inc.
AINC
$2.23K ﹤0.01%
43
+18
+72% +$1.13K
FCEL icon
3682
FuelCell Energy
FCEL
$1.63B
$2.21K ﹤0.01%
11
+4
+57% +$1.14K
LUMO
3683
DELISTED
Lumos Pharma, Inc. Common Stock
LUMO
$2.21K ﹤0.01%
161
+79
+96% +$1.39K
MLNT
3684
DELISTED
Melinta Therapeutics, Inc. Common Stock
MLNT
$2.21K ﹤0.01%
556
+426
+328% +$5.45K
AVXL icon
3685
Anavex Life Sciences
AVXL
$303M
$2.19K ﹤0.01%
1,404
+94
+7% +$213
PLSE icon
3686
Pulse Biosciences
PLSE
$3.2B
$2.19K ﹤0.01%
191
-160
-46% -$1.94K
IEMG icon
3687
iShares Core MSCI Emerging Markets ETF
IEMG
$159B
$2.17K ﹤0.01%
46
RNWK
3688
DELISTED
RealNetworks Inc
RNWK
$2.17K ﹤0.01%
938
CBNK icon
3689
Capital Bancorp
CBNK
$616M
$2.1K ﹤0.01%
+184
New +$2.29K
PCYO icon
3690
Pure Cycle
PCYO
$273M
$2.1K ﹤0.01%
211
-371
-64% -$3.76K
VHI icon
3691
Valhi
VHI
$466M
$2.09K ﹤0.01%
90
+20
+29% +$502
GSIT icon
3692
GSI Technology
GSIT
$260M
$2.09K ﹤0.01%
406
+26
+7% +$152
VIVE
3693
DELISTED
VIVEVE MED INC
VIVE
$2.06K ﹤0.01%
2
AREX
3694
DELISTED
Approach Resources Inc.
AREX
$2.06K ﹤0.01%
2,362
+833
+54% +$1.27K
ASXC
3695
DELISTED
Asensus Surgical, Inc.
ASXC
$2.05K ﹤0.01%
+70
New +$3.18K
FSTX
3696
DELISTED
F-star Therapeutics, Inc. Common Stock
FSTX
$2.05K ﹤0.01%
49
-42
-46% -$1.89K
XOMA
3697
DELISTED
Xoma
XOMA
$2.04K ﹤0.01%
161
-26
-14% -$372
DNBF
3698
DELISTED
DNB Financial Corp
DNBF
$2.02K ﹤0.01%
71
+7
+11% +$238
AVEO
3699
DELISTED
AVEO Pharmaceuticals, Inc.
AVEO
$2.01K ﹤0.01%
126
-206
-62% -$4.53K
LOVE
3700
LoveSac
LOVE
$258M
$2K ﹤0.01%
+87
New +$1.8K

Similar funds

BNP Paribas Financial Markets's Q4 2018 Portfolio in Review

As of Q4 2018, BNP Paribas Financial Markets held 4,572 positions worth $42.3B, down 38% from $67.7B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

BNP Paribas Financial Markets withdrew a net $18.9B in Q4 2018, closing 248 positions and reducing 2,296 holdings. Its most notable exit was Aetna Inc, an estimated $141M position sold in full.

By sector, the portfolio is most concentrated in Technology at 7% of assets, down from 9.5% a quarter earlier, followed by Financials and Healthcare.

Against the trend, BNP Paribas Financial Markets opened a new position in HUTCHMED worth $8.84M.

  • BNP Paribas Financial Markets's largest Q4 2018 buy was HUTCHMED: 382,749 shares worth $8.84M.
  • BNP Paribas Financial Markets added most to Celgene Corp in Q4 2018, an estimated $151M increase.
  • BNP Paribas Financial Markets's biggest Q4 2018 reduction was Alphabet (Google) Class C, cutting an estimated $1.15B.
  • BNP Paribas Financial Markets fully exited Aetna Inc in Q4 2018, selling an estimated $141M.
  • BNP Paribas Financial Markets's ten largest holdings make up 19% of its $42.3B portfolio in Q4 2018.
  • BNP Paribas Financial Markets opened 126 new positions and closed 248 in Q4 2018.
  • BNP Paribas Financial Markets's portfolio value fell 38% quarter-over-quarter to $42.3B.

Based on BNP Paribas Financial Markets's 13F filing for Q4 2018, filed 12 Feb 2019.